The losses persisted despite the fact that AmSurg generated roughly $55 million in earnings, sources told Bloomberg.
The company reported a loss of $26 million for the quarter, down from an alleged $221 million gain in the second quarter of 2021, sources told Bloomberg. According to the report, the losses can be attributed to high labor costs, changes in insurance plans and an ongoing contract fight with payer UnitedHealth, among other reasons.
Envision’s total revenue declined around 12.6 percent year-over-year to $1.6 billion. To combat the loss, Envision has been taking many of its out-of-network contracts and moving them in network.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.